• DRAMP ID

    • DRAMP21450
    • Peptide Name

    • peptide 27 (Derived from B1)
    • Source

    • synthetic construct
    • Family

    • Not found
    • Gene

    • Not found
    • Sequence

    • KKKxAYA
    • Sequence Length

    • 7
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Synthetic form
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-
    • Target Organism

      • [Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=2-4 µg/ml), MSSA ATCC 29213(MIC=64 µg/ml);
      • Gram-negative bacteria: Pseudomonas aeruginosa(MIC=64 µg/ml)
    • Hemolytic Activity

      • [Ref.30842436] EC10=3μM, EC50=56μM, 54% hemolysis at 150 µM against human red blood cells
    • Cytotoxicity

    • No cytotoxicity information found in the reference(s) presented
    • Binding Target

    • Not found
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • Nle4 is norleucine. Residue 5 and residue 7 are 2-naphthylmethylglycine.
    • Stereochemistry

    • L
    • Structure

    • Unknown
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP21450 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP21450.
    • Formula

    • C33H55N9O7
    • Absent Amino Acids

    • CDEFGHILMNPQRSTVW
    • Common Amino Acids

    • K
    • Mass

    • 819.2
    • PI

    • 10
    • Basic Residues

    • 3
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 2
    • Net Charge

    • +3
    • Boman Index

    • -1317
    • Hydrophobicity

    • -1.343
    • Aliphatic Index

    • 28.57
    • Half Life

      • Mammalian:1.3 hour
      • Yeast:3 min
      • E.coli:2 min
    • Extinction Coefficient Cystines

    • 1490
    • Absorbance 280nm

    • 248.33
    • Polar Residues

    • 1

DRAMP21450

    • Function

    • Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.
  • ·Literature 1
    • Title

    • Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections
    • Reference

    • Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3
    • Author

    • Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen